This research identifies brain iron biomarkers in first-episode psychosis patients, suggesting improved treatment response prediction using machine learning.
Motivation: The research aims to improve diagnostic accuracy and treatment strategies for First-Episode Psychosis by identifying critical brain iron biomarkers. Goal(s): The present study aims to pinpoint potential predictive biomarkers derived from QSM and R2* for individuals experiencing first-episode-psychosis (FEP), along with their response to antipsychotic treatment. Approach: The study used MRI to assess brain iron levels in psychosis patients, employing machine learning for classification and treatment response prediction. Results: The study achieved 76.48% accuracy in classifying healthy individuals from First-Episode Psychosis patients and 76.43% accuracy in predicting treatment responses, identifying key biomarkers linked to dopamine pathways. Impact: This study identifies key brain iron concentration biomarkers using QSM and R2* in FEP, achieving 76% classification accuracy. It highlights the potential for improved early detection and treatment response prediction, paving the way for enhanced clinical outcomes in schizophrenia management.
No takes yet. Share an insight, caveat, or question.
Franco et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: